Literature DB >> 23471742

Diabetes mellitus and osteoporosis.

Robert Sealand1, Christie Razavi, Robert A Adler.   

Abstract

Diabetes mellitus (particularly type 2) and osteoporosis are two very common disorders, and both are increasing in prevalence. Adolescents with type 1 diabetes mellitus may not reach potential peak bone mass, putting them at greater fracture risk. In adults with type 2 diabetes, fracture risk is increased and is not explained by the bone mineral density measured by dual-energy X-ray absorptiometry, still considered the gold standard predictor of fracture. In this review, we explore potential mechanisms behind the increased fracture risk that occurs in patients with diabetes, even those with increased bone mineral density. One potential link between diabetes and bone is the osteoblast-produced factor, osteocalcin. It remains to be established whether osteocalcin reflects or affects the connection between bone and glucose metabolism. Several other potential mediators of the effects of diabetes on bone are discussed.

Entities:  

Mesh:

Year:  2013        PMID: 23471742     DOI: 10.1007/s11892-013-0376-x

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  72 in total

Review 1.  Type 2 diabetes and bone.

Authors:  William D Leslie; Mishaela R Rubin; Ann V Schwartz; John A Kanis
Journal:  J Bone Miner Res       Date:  2012-09-28       Impact factor: 6.741

2.  Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study.

Authors:  Denise E Bonds; Joseph C Larson; Ann V Schwartz; Elsa S Strotmeyer; John Robbins; Beatriz L Rodriguez; Karen C Johnson; Karen L Margolis
Journal:  J Clin Endocrinol Metab       Date:  2006-06-27       Impact factor: 5.958

3.  Hydrogen peroxide, but not superoxide, stimulates bone resorption in mouse calvariae.

Authors:  J H Fraser; M H Helfrich; H M Wallace; S H Ralston
Journal:  Bone       Date:  1996-09       Impact factor: 4.398

4.  Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways.

Authors:  Elena J Moerman; Kui Teng; David A Lipschitz; Beata Lecka-Czernik
Journal:  Aging Cell       Date:  2004-12       Impact factor: 9.304

5.  Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus.

Authors:  Ippei Kanazawa; Toru Yamaguchi; Masahiro Yamamoto; Mika Yamauchi; Soichi Kurioka; Shozo Yano; Toshitsugu Sugimoto
Journal:  J Clin Endocrinol Metab       Date:  2008-11-04       Impact factor: 5.958

Review 6.  Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus.

Authors:  M Saito; K Marumo
Journal:  Osteoporos Int       Date:  2010-02       Impact factor: 4.507

7.  Does low bone mineral density start in post-teenage years in women with type 1 diabetes?

Authors:  Emily Y Liu; Jean Wactawski-Wende; Richard P Donahue; Jacek Dmochowski; Kathleen M Hovey; Teresa Quattrin
Journal:  Diabetes Care       Date:  2003-08       Impact factor: 19.112

8.  The association between fracture site and obesity in men: a population-based cohort study.

Authors:  Melissa O Premaor; Juliet E Compston; Francesc Fina Avilés; Aina Pagès-Castellà; Xavier Nogués; Adolfo Díez-Pérez; Daniel Prieto-Alhambra
Journal:  J Bone Miner Res       Date:  2013-08       Impact factor: 6.741

9.  Amylin fasting plasma levels are decreased in patients with osteoporosis.

Authors:  J Bronský; R Průsa
Journal:  Osteoporos Int       Date:  2003-11-07       Impact factor: 4.507

10.  Bone mineral density in diabetic children and adolescents: a follow-up study.

Authors:  Alessandro Salvatoni; Gianmaria Mancassola; Roberta Biasoli; Roberta Cardani; Silvia Salvatore; Marco Broggini; Luigi Nespoli
Journal:  Bone       Date:  2004-05       Impact factor: 4.398

View more
  24 in total

1.  Increasing fasting glucose and fasting insulin associated with elevated bone mineral density-evidence from cross-sectional and MR studies.

Authors:  H Zhou; C Li; W Song; M Wei; Y Cui; Q Huang; Q Wang
Journal:  Osteoporos Int       Date:  2021-01-06       Impact factor: 4.507

2.  The impact of vitamin D levels on glycemic control and bone mineral density in postmenopausal women with type 2 diabetes.

Authors:  I Perez-Diaz; G Sebastian-Barajas; Z G Hernandez-Flores; R Rivera-Moscoso; H K Osorio-Landa; A Flores-Rebollar
Journal:  J Endocrinol Invest       Date:  2015-12       Impact factor: 4.256

3.  Risk of osteoporosis and fracture in victims with burn injury.

Authors:  O Kaewboonchoo; F C Sung; C L Lin; H C Hsu; C T Kuo
Journal:  Osteoporos Int       Date:  2019-02-08       Impact factor: 4.507

4.  Comparison of osteoporosis in US adults with type 1 and type 2 diabetes mellitus.

Authors:  S C DeShields; T D Cunningham
Journal:  J Endocrinol Invest       Date:  2018-01-20       Impact factor: 4.256

5.  [Diabetes and osteoporosis: pathophysiological interactions and clinical importance for geriatric patients].

Authors:  M Lechleitner; K Pils; R Roller-Wirnsberger; E Beubler; R Gasser; P Mrak; F Hoppichler; P Pietschmann
Journal:  Z Gerontol Geriatr       Date:  2013-07       Impact factor: 1.281

Review 6.  Derangement of calcium metabolism in diabetes mellitus: negative outcome from the synergy between impaired bone turnover and intestinal calcium absorption.

Authors:  Kannikar Wongdee; Nateetip Krishnamra; Narattaphol Charoenphandhu
Journal:  J Physiol Sci       Date:  2016-09-26       Impact factor: 2.781

7.  Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fractures.

Authors:  Bipradas Roy
Journal:  World J Diabetes       Date:  2013-08-15

8.  Effects of losartan treatment on the physicochemical properties of diabetic rat bone.

Authors:  Baris Ozgur Donmez; Mustafa Unal; Semir Ozdemir; Nihal Ozturk; Nurettin Oguz; Ozan Akkus
Journal:  J Bone Miner Metab       Date:  2016-04-02       Impact factor: 2.626

9.  Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.

Authors:  C Tsentidis; D Gourgiotis; L Kossiva; A Doulgeraki; A Marmarinos; A Galli-Tsinopoulou; K Karavanaki
Journal:  Osteoporos Int       Date:  2015-11-20       Impact factor: 4.507

10.  EFFECT OF PUERARIN ON THE PROLIFERATION AND DIFFERENTIATION OF OSTEOBLASTS AND THE EXPRESSION OF TYPE I COLLAGEN mRNA IN A HIGH-GLUCOSE ENVIRONMENT.

Authors:  X H Wang; X W Shi; X X Luo; D H Zhang
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jul-Sep       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.